Refractive and visual outcomes after combined cataract and trabectome surgery

Lübke, Jan; Boehringer, Daniel; Neuburger, M.; Anton, Alexandra; Wecker, Thomas; Cakir, Bertan; Reinhard, Thomas; Jordan, Jens

doi:10.1007/s00417-014-2881-2

Cited by 27 publications

(13 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another advantage of MIGS strategies is a reduced risk of a large refractive surprise compared to conventional filtering operations and faster visual rehabilitation. 17 Sieck et al concluded that there were no difference found between the refractive outcomes of glaucoma patients with or without KDB. 18 Also, in 2020 a study result that iStent inject does not risk refractive outcomes and can be paired with cataract procedure safely.…”

Section: Discussionmentioning

confidence: 99%

<p>Quality of Life After Combined Cataract and Minimally Invasive Glaucoma Surgery in Glaucoma Patients</p>

Habash¹,

Nagshbandi²

2020

OPTH

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

<p>Quality of Life After Combined Cataract and Minimally Invasive Glaucoma Surgery in Glaucoma Patients</p>

Habash¹,

Nagshbandi²

2020

OPTH

View full text Add to dashboard Cite

show abstract

“…It has been shown that scleral IOL fixation results in more lens tilt than regular cataract surgery with in-the-bag-placement of the IOL [27, 28]. One could well imagine that instability could be worsened in MFS eyes in general by the weakened tissue itself and by damaged ocular structures from trauma or chronic inflammatory conditions.…”

Section: Discussionmentioning

confidence: 99%

Long-term follow-up after scleral lens fixation in patients with Marfan syndrome

et al. 2017

Self Cite

View full text Add to dashboard Cite

BackgroundThe dislocation of the crystalline lens is a common finding in patients with Marfan syndrome (MFS). Scleral intraocular lens (IOL) fixation is an accepted treatment method of this complication. To now, no long-term data on scleral IOL fixation in MFS exist.MethodsWe present a retrospective study of 27 eyes of 17 MFS patients that underwent scleral lens fixation at our clinic between 1999 and 2012. These patients are compared to an age- and surgeon-matched group of 31 eyes of 27 patients who underwent the same procedure for reasons other than MFS.ResultsThe median age in the MFS group was 35.4 years versus 35.6 years in the non-MFS group. The median follow-up was 4 years for MFS and 3 years for non-MFS. In the MFS group, significantly more IOL-dislocations occurred than compared to the non-MFS group (30% vs. 6.5%, p = 0.02). Retinal detachment occurred in four MFS-eyes compared to three eyes in the non-MFS group. Biometry prediction error was 1.11 diopters (D) for MFS and 1.33 D for non-MFS (p = 0.11). Median BCVA (best-corrected visual acuity, logMAR) was 0.1 in the MFS group versus 0.3 in non-MFS patients.ConclusionScleral lens fixation in MFS patients achieves satisfying visual and refractive outcomes. Our data shows a significantly higher rate of IOL dislocations in patients with MFS. We therefore recommend addressing this complication preoperatively.Electronic supplementary materialThe online version of this article (10.1186/s12886-017-0625-x) contains supplementary material, which is available to authorized users.

show abstract

“… 19 Luebke et al showed, in a retrospective review of 137 patients at the University Eye Hospital in Freiburg, Germany, that visual outcomes were not statistically different in patients that had cataract surgery with and without Trabectome; however, the rate of cystoid macula edema was slightly higher (2.2% in combined surgery vs 1.9% in cataract surgery alone). 20 In the reported studies here, 9 – 12 , 14 , 15 , 17 , 18 there have been no reports of infection, choroidal effusion, choroidal hemorrhage, or wound leaks.…”

Section: Increasing Trabecular Flowmentioning

confidence: 68%

Minimally invasive glaucoma surgery: current status and future prospects

Richter¹,

Coleman²

2016

OPTH

188

127

View full text Add to dashboard Cite

Minimally invasive glaucoma surgery aims to provide a medication-sparing, conjunctival-sparing, ab interno approach to intraocular pressure reduction for patients with mild-to-moderate glaucoma that is safer than traditional incisional glaucoma surgery. The current approaches include: increasing trabecular outflow (Trabectome, iStent, Hydrus stent, gonioscopy-assisted transluminal trabeculotomy, excimer laser trabeculotomy); suprachoroidal shunts (Cypass micro-stent); reducing aqueous production (endocyclophotocoagulation); and subconjunctival filtration (XEN gel stent). The data on each surgical procedure for each of these approaches are reviewed in this article, patient selection pearls learned to date are discussed, and expectations for the future are examined.

show abstract

Refractive and visual outcomes after combined cataract and trabectome surgery

Abstract: Refractive and visual outcomes were similar in both groups. Despite the slightly higher rate of postoperative macula edema, we were able to observe that the combination of these two procedures is a feasible method in glaucoma and cataract surgeries.

Cited by 27 publications

References 17 publications

<p>Quality of Life After Combined Cataract and Minimally Invasive Glaucoma Surgery in Glaucoma Patients</p>

<p>Quality of Life After Combined Cataract and Minimally Invasive Glaucoma Surgery in Glaucoma Patients</p>

Long-term follow-up after scleral lens fixation in patients with Marfan syndrome

Minimally invasive glaucoma surgery: current status and future prospects

Contact Info

Product

Resources

About